Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Allient Inc. ALNT |
FMR CORP | 1,789,650 10.600% |
196,010 (+12.30%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Fortrea Holdings Inc. FTRE |
FMR CORP | 9,296,766 10.400% |
1,209,960 (+14.96%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Sweetgreen, Inc. SG |
FMR CORP | 10,748,949 10.400% |
974,770 (+9.97%) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Civeo Corporation CVEO |
FMR CORP | 704,037 5.100% |
-842,801 (-54.49%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Duolingo, Inc. DUOL |
FMR CORP | 3,943,460 10.400% |
216,899 (+5.82%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | REAL GOOD FOOD CO INC RGFC |
FMR CORP | 43,691 2.500% |
43,691 (New Position) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Miller Industries, Inc. MLR |
FMR CORP | 1,169,165 10.200% |
402,542 (+52.51%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | The Chemours Company CC |
FMR CORP | 15,258,749 10.200% |
525,186 (+3.56%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Outfront Media Inc. OUT |
FMR CORP | 19,475,103 12.000% |
19,475,103 (New Position) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 2,695,007 2.500% |
-8,426,644 (-75.77%) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Poseida Therapeutics, Inc. PSTX |
FMR CORP | 0 0.000% |
-10,011,617 (Position Closed) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
FMR CORP | 9,631,638 10.400% |
727,552 (+8.17%) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | JPMorgan International Research Enhanced Equity ETF JIRE |
FMR CORP | 2,775,059 2.500% |
-8,383,176 (-75.13%) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Arch Resources, Inc. ARCH |
FMR CORP | 0 0.000% |
-2,124,288 (Position Closed) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR CORP | 480,507 0.400% |
-4,755,014 (-90.82%) |
Filing History |
| 2025-02-07 10:23 am Purchase |
2025-01-31 | 13G | Builders FirstSource, Inc. BLDR |
FMR CORP | 11,869,674 10.300% |
1,711,525 (+16.85%) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Keros Therapeutics, Inc. KROS |
FMR CORP | 704,472 1.700% |
-3,169,732 (-81.82%) |
Filing History |
| 2025-02-07 10:21 am Purchase |
2025-01-31 | 13G | Dimensional Emerging Markets Value ETF DFEV |
FMR CORP | 4,283,321 12.400% |
4,283,321 (New Position) |
Filing History |
| 2025-02-07 10:18 am Purchase |
2025-01-31 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 6,318,721 15.000% |
2,395,122 (+61.04%) |
Filing History |
| 2025-02-07 10:06 am Purchase |
2024-12-31 | 13G | Duolingo, Inc. DUOL |
FMR CORP | 3,726,561 9.800% |
1,063,328 (+39.93%) |
Filing History |